Cefepime/enmetazobactam
Kathryn Dzintars, Pharm.D., BCPS
INDICATIONS
INDICATIONS
INDICATIONS
FDA
FDA
FDA
Exblifep (cefepime/enmetazobactam) is indicated in patients 18 years and older for the treatment of
complicated urinary tract infections (cUTI)
, including pyelonephritis.
NON-FDA APPROVED USES
NON-FDA APPROVED USES
NON-FDA APPROVED USES
Resistant Gram-negative infections, including ESBL-producing and certain carbapenemase-producing bacteria
There's more to see -- the rest of this topic is available only to subscribers.
© 2000–2025 Unbound Medicine, Inc. All rights reserved
All content is protected by copyright and may not be used for AI model training or other unauthorized purposes.